Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Basic Research in Cardiology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-642-85660-0_6PMID 7945177
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Are Aortic Aneurysms Caused by Atherosclerosis?

  1992cited by this paper
• Proteinases and glomerular matrix turnover.

  1992cited by this paper
• Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation.

  1992cited by this paper
• Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF

  1991cited by this paper
• Metalloproteinases and tissue damage.

  1991cited by this paper
• Potent collagenase inhibitors prevent interleukin-1-induced cartilage degradation in vitro.

  1991cited by this paper
• Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells.

  1991cited by this paper
• Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization.

  1991cited by this paper
• Matrix metalloproteinases and their inhibitors in connective tissue remodeling

  1991cited by this paper
• Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

  1991cited by this paper
• Metalloproteinases and their inhibitors in matrix remodeling.

  1990cited by this paper
• Atherogenesis during low level hypercholesterolemia in the nonhuman primate. I. Fatty streak formation.

  1990cited by this paper
• Regulation of differentiated properties and proliferation of arterial smooth muscle cells.

  1990cited by this paper
• Serum-induced proliferation of rabbit aortic smooth muscle cells from the contractile state is inhibited by 8-Br-cAMP but not 8-Br-cGMP.

  1990cited by this paper
• Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery.

  1990cited by this paper
• Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity

  1990cited by this paper
• Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2- macroglobulin inactive complex

  1989cited by this paper
• Cell biology of arterial proteoglycans.

  1989cited by this paper
• Synthesis of latent collagenase and collagenase inhibitor by bovine aortic medial explants and cultured medial smooth muscle cells.

  1989cited by this paper
• Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells

  1988cited by this paper
• Replication of Smooth-Muscle Cells in Atherosclerosis

  1988cited by this paper
• The pathogenesis of atherosclerosis--an update.

  1986cited by this paper
• Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors.

  1986cited by this paper
• Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin.

  1986cited by this paper
• Morphological characteristics of clinically significant coronary artery stenosis in stable angina.

  1986cited by this paper
• Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity.

  1986cited by this paper
• Endothelial regeneration. VII. Lack of intimal proliferation after defined injury to rat aorta.

  1985cited by this paper
• Textbook of rheumatology

  1985cited by this paper
• Studies of Hypercholesterolemia in the Nonhuman Primate: I. Changes that Lead to Fatty Streak Formation

  1984cited by this paper
• Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima. Light-microscopic study of dissociated aortic cells.

  1984cited by this paper
• Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium.

  1983cited by this paper
• Synthesis of connective tissue macromolecules by smooth muscle.

  1979cited by this paper
• The pathogenesis of atherosclerosis (first of two parts).

  1976cited by this paper
• Hypertension and atherosclerosis.

  1969cited by this paper

• Luteolin Ameliorates Experimental Pulmonary Arterial Hypertension via Suppressing Hippo-YAP/PI3K/AKT Signaling Pathway

  2021cites this paper
• Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme

  2021cites this paper
• Change in matrix metalloproteinase 2, 3, and 9 levels at the time of and after acute atherothrombotic myocardial infarction

  2019cites this paper
• Serum prolidase enzyme activity in obese subjects and its relationship with oxidative stress markers.

  2017cites this paper
• The short and medium term effects of Endovascular Aneurysm Repair (EVAR) on coagulation, fibrinolysis and renal function in patients with Abdominal Aortic Aneurysms

  2017cites this paper
• Collagen and Collagenases: A Brief Review

  2017cites this paper
• Matrix‐Metalloproteinase‐2 Predicts Arteriovenous Fistula Failure in Hemodialysis Patients

  2017cites this paper
• Oxidative theory of atherosclerosis and antioxidants.

  2016cites this paper
• Association Between −1562C>T Polymorphism in the Promoter Region of Matrix Metalloproteinase-9 and Coronary Artery Disease: A Meta-Analysis

  2014cites this paper
• Leptin and vascular smooth muscle cells.

  2014cites this paper
• Serum prolidase enzyme activity and oxidative stress levels in patients with diabetic neuropathy

  2014cites this paper
• Lipid: Extracellular Matrix Interactions as Therapeutic Targets in the Atherosclerosis of Diabetes

  2014cites this paper
• Increased Expression of p-Akt correlates with Chronic Allograft Nephropathy in a Rat Kidney Model

  2014cites this paper
• Dramatic early event in chronic allograft nephropathy: increased but not decreased expression of MMP-9 gene

  2013cites this paper
• Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications

  2013cites this paper
• Pathophysiological Mechanisms of Carotid Plaque Vulnerability: Impact on Ischemic Stroke

  2012cites this paper
• The association between soluble lectin-like oxidized low-density lipoprotein receptor-1 levels and patients with isolated coronary artery ectasia

  2012cites this paper
• PP-018 THE ASSOCIATION BETWEEN SOLUBLE LECTIN-LIKE OXIDIZED LOW-DENSITY LIPOPROTEIN RECEPTOR-1 LEVELS AND PATIENTS WITH ISOLATED CORONARY ARTERY ECTASIA

  2012cites this paper
• Overexpression of matrix metalloproteinase-1 (MMP-1) and MMP-3 in superior limbic keratoconjunctivitis.

  2011cites this paper
• Oxidative Stress and β-Amyloid Protein in Alzheimer’s Disease

  2011cites this paper
• Leptin and cardiovascular function in African and Caucasian men and women : the SABPA study

  2011cites this paper
• Toxicological Insight from AP-1 Silencing Study on Proliferation, Migration, and Dedifferentiation of Rat Vascular Smooth Muscle Cell

  2011cites this paper
• Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression.

  2011cites this paper
• The association of serum prolidase activity and erectile dysfunction.

  2010influential citation
• Titin is a Target of Matrix Metalloproteinase-2: Implications in Myocardial Ischemia/Reperfusion Injury

  2010cites this paper
• In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor.

  2010cites this paper
• A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease.

  2010cites this paper
• A protein deacetylase SIRT1 is a negative regulator of metalloproteinase‐9

  2009cites this paper
• Glycogen synthase kinase-3beta is activated by matrix metalloproteinase-2 mediated proteolysis in cardiomyoblasts.

  2009cites this paper
• The role of vascular matrix metalloproteinase-2 and heme oxygenase-2 in mediating the response to hypoxia.

  2009cites this paper
• Long-term treatment with the AT1-receptor antagonist telmisartan inhibits biglycan accumulation in murine atherosclerosis

  2009cites this paper
• In Situ Bioengineering of Arterial Vein Grafts

  2008influential citation
• A primer on the immune system in the pathogenesis and treatment of atherosclerosis.

  2008cites this paper
• Increased Matrix Metalloproteinase 2 Activity in the Human Internal Mammary Artery Is Associated with Ageing, Hypertension, Diabetes and Kidney Dysfunction

  2008cites this paper
• The association of serum prolidase activity with the presence and severity of coronary artery disease

  2008cites this paper
• The transcription factor KLF2 in vascular biology

  2008cites this paper
• UvA-DARE ( Digital Academic Repository ) The transcription factor KLF 2 in vascular biology

  2008cites this paper
• Matrix metalloproteinase-3 induction in rat brain astrocytes: focus on the role of two AP-1 elements.

  2008cites this paper
• p38 MAP-kinases pathway regulation, function and role in human diseases.

  2007cites this paper
• CHAPTER 35 – Atherothrombosis and Coronary Artery Disease

  2007cites this paper
• Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury.

  2007cites this paper
• Increased plasma levels of cystatin C and transforming growth factor-&bgr;1 in patients with coronary artery ectasia: can there be a potential interaction between cystatin C and transforming growth factor-&bgr;1

  2007cites this paper
• Apoptosis Is Abundant in Human Atherosclerotic Lesions, Especially in Inflammatory Cells (Macrophages and T Cells), and May Contribute to the Accumulation of Gruel and Plaque Instability

  2007cites this paper
• Gelatinolytic Activity in Atherosclerotic Plaques Is Highly Localized and Is Associated With Both Macrophages and Smooth Muscle Cells In Vivo

  2007cites this paper
• Increased plasma levels of cystatin C and transforming growth factor-beta1 in patients with coronary artery ectasia: can there be a potential interaction between cystatin C and transforming growth factor-beta1.

  2007cites this paper
• Inflammation and Infection in Coronary Artery Disease

  2006cites this paper
• Cystatin C levels are decreased in acute myocardial infarction: effect of cystatin C G73A gene polymorphism on plasma levels.

  2005cites this paper
• Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin.

  2005cites this paper
• In vivo temperature heterogeneity is associated with plaque regions of increased MMP-9 activity.

  2005cites this paper
• Gelatinase B C(‐1562)T polymorphism in relation to ischaemic heart disease

  2005cites this paper
• Homocysteine-induced vascular dysregulation is mediated by the NMDA receptor

  2005cites this paper
• A comparison of six statins on the development of intimal hyperplasia in a human vein culture model.

  2005cites this paper
• Modulation of collagen turnover in cardiovascular disease.

  2005cites this paper
• Tissue factor pathway inhibitor-2 (TFPI-2) recognizes the complement and kininogen binding protein gC1qR/p33 (gC1qR): implications for vascular inflammation

  2004cites this paper
• Tyrosine phosphatase inhibition induces loss of blood-brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways.

  2004cites this paper
• Lysosomal Cysteine Proteases in Atherosclerosis

  2004cites this paper
• Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches.

  2004cites this paper
• Effect of a Synthetic Matrix Metalloproteinase Inhibitor (ONO-4817) on Neointima Formation in Hypercholesterolemic Hamsters

  2004cites this paper
• Stromelysin-1 (MMP-3) gene 5A/6A promoter polymorphism is associated with blood pressure in a community population.

  2004cites this paper
• TIMP-1 stimulates proliferation of human aortic smooth muscle cells and Ras effector pathways.

  2004cites this paper
• Matrix metalloproteinase inhibition reduces intimal hyperplasia in a porcine arteriovenous-graft model.

  2004cites this paper
• S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells

  2003cites this paper
• , Andrea Rupture of the Atherosclerotic Plaque : Does a Good Animal Model Exist ?

  2003cites this paper
• LOX-1 Mediates Oxidized Low-Density Lipoprotein-Induced Expression of Matrix Metalloproteinases in Human Coronary Artery Endothelial Cells

  2003cites this paper
• ATVB in Focus Lipoproteins, Inflammation, and Atherosclerosis

  2003cites this paper
• Rupture of the Atherosclerotic Plaque: Does a Good Animal Model Exist?

  2003cites this paper
• Alterations in the vascular extracellular matrix of granulocyte macrophage colony‐stimulating factor (GM‐CSF) ‐deficient mice

  2003cites this paper
• Atherosclerotic plaque morphology in diabetes type 2 patients

  2003cites this paper
• The effect of rapamycin after cyclosporin dose reduction on chronic allograft nephropathy

  2003cites this paper
• ATVB In Focus: Lipoproteins, Inflammation, and Atherosclerosis

  2003cites this paper
• Coronary artery calcification is related to functional polymorphism of matrix metalloproteinase 3: the Helsinki Sudden Death Study.

  2002cites this paper
• Sulphur: the vulnerable factor X in atherosclerosis.

  2002cites this paper
• Increased MMP-2 Expression in Connective Tissue Growth Factor Over-expression Vascular Smooth Muscle Cells*

  2002cites this paper
• Differential effects of gemfibrozil on migration, proliferation and proteoglycan production in human vascular smooth muscle cells.

  2002cites this paper
• Tissue inhibitor of metalloproteinases-4 and progelatinase A activation : the role of the C-terminal tail in mediating activation

  2002cites this paper
• Interaction between smoking and the stromelysin‐1 (MMP3) gene 5A/6A promoter polymorphism and risk of coronary heart disease in healthy men

  2002cites this paper
• Methods for Analysis of Matrix Metalloproteinase Regulation of Neutrophil-Endothelial Cell Adhesion

  2002influential citation
• Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention

  2002cites this paper
• The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis.

  2002cites this paper
• Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration.

  2002cites this paper
• Interaction between smoking and the stromelysin-1 (MMP3) gene 5A/6A promoter polymorphism and risk of coronary heart disease in healthy men.

  2002cites this paper
• The Stromelysin-1 5A/6A Promoter Polymorphism Is a Disease Marker for the Extent of Coronary Heart Disease

  2002cites this paper
• Pathophysiology of plaque instability: insights at the genomic level.

  2002cites this paper
• Pharmacogenetics and Pharmacogenomics in

  2002cites this paper
• Molecular Biology of Vascular Remodeling

  2002cites this paper
• Coronary Artery Complicated Lesion Area Is Related to Functional Polymorphism of Matrix Metalloproteinase 9 Gene: An Autopsy Study

  2001cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper
• Expression of metalloproteinases and its inhibitor in later stage of rabbit neointima development.

  2001cites this paper
• Matrix metalloproteinases and their inhibitors in oral lichen planus

  2001cites this paper
• Statins for the prevention of vein graft stenosis: a role for inhibition of matrix metalloproteinase-9.

  2001cites this paper
• Native and minimally oxidized low density lipoprotein depress smooth muscle matrix metalloproteinase levels

  2001cites this paper
• Perivascular Responses after Angioplasty Which May Contribute to Postangioplasty Restenosis

  2001cites this paper
• Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis.

  2001cites this paper
• Matrix metalloproteinases regulate neutrophil‐endothelial cell adhesion through generation of endothelin‐1[1–32]

  2001cites this paper
• Stromelysin-1 and Interleukin-6 Gene Promoter Polymorphisms Are Determinants of Asymptomatic Carotid Artery Atherosclerosis

  2000cites this paper
• Marimastat inhibits neointimal thickening in a model of human arterial intimal hyperplasia.

  2000cites this paper
• A cardiovascular EST repertoire: progress and promise for understanding cardiovascular disease.

  2000cites this paper
• Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.

  1999cites this paper
• Production and inhibition of the gelatinolytic matrix metalloproteinases in a human model of vein graft stenosis.

  1999cites this paper
• Differential Regulation of Platelet Aggregation by Matrix Metalloproteinases-9 and -2

  1999cites this paper